Lurie Children’s Division of Allergy and Immunology is at the cutting edge of eczema clinical research. We offer our patients with eczema the newest treatments as well as opportunities to be part of studies in hopes to discover more treatments and a cure.
We are currently recruiting patients in numerous eczema studies. Learn more about our current trials:
Atopic Dermatitis and Sleep Study This study looks at eczema flares that may happen during the sleep cycle in patients 15 to 25 years old. Click here or call 312.227.6021 for more information.
Infants with Moderate-Severe Eczema and/or Egg Allergy and Peanut Allergy: Discovering a Significant Genotype This study of children 4 - 11 months with moderate to severe eczema or egg allergy looks to find biomarkers to help tell us whether or not a child will develop a peanut allergy and how severe a peanut allergy might be. Click here for the full study information or call 312.227.5391 for more information.
Eucrisa in Atopic Dermatitis This study is looking to evaluate the effectiveness of a tissue biomarker to predict whether the topical medicine, Eucrisa, will be helpful to treat the patients’s eczema. If interested, contact email@example.com or call 312.227.6021.
Pediatric Eczema Decision Aid Research Study This is a study looking to help patients and doctors decide together which eczema treatment option is best for them. Click here for the full study information or call 872.204.7919 for more information.
Itch Cognitive Behavioral Therapy Intervention The purpose of this study is to use a type of cognitive-behavioral therapy (CBT) to improve itch symptoms in children with moderate to severe eczema. Click here for the full study information or call 312.503.1469 for more information.